These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15224812)

  • 1. The influence of dialyzer type on serum albumin in hemodialysis patients.
    Galler M; Schwenk MH; Parthiban KC; Palecki W
    Clin Nephrol; 2004 Jun; 61(6):449-50. PubMed ID: 15224812
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of dialyzer membrane on serum albumin levels in patients receiving hemodialysis.
    Rault RM
    Int J Artif Organs; 2003 Nov; 26(11):1002-4. PubMed ID: 14708829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hemodialysis membranes on serum albumin.
    Locatelli F;
    Am J Kidney Dis; 2001 Feb; 37(2):455-6. PubMed ID: 11157397
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes.
    Memoli B; Minutolo R; Bisesti V; Postiglione L; Conti A; Marzano L; Capuano A; Andreucci M; Balletta MM; Guida B; Tetta C;
    Am J Kidney Dis; 2002 Feb; 39(2):266-73. PubMed ID: 11840366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethylene-vinyl alcohol copolymer dialyzer membrane reduces protein oxidation in hemodialysis patients.
    Matsumoto Y; Mukai M; Arihara K; Saito T; Kumagai H
    Ren Fail; 2011; 33(4):382-7. PubMed ID: 21529266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dialyzer membranes on beta-2 microglobulin production in Thai hemodialysis patients.
    Domrongkitchaiporn S; Chuncharunee S; Archararit N; Atamasirikul K; Vanichakarn S
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S138-43. PubMed ID: 9347661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialyzer permeability for low-molecular-weight proteins. Comparison between polysulfone, polyamide and cuprammonium-rayon dialyzers.
    Nensel U; Röckel A; Hillenbrand T; Bartel J
    Blood Purif; 1994; 12(2):128-34. PubMed ID: 7530014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
    Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
    Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
    Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH
    Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatible dialysis membranes do not reduce plasma leptin levels.
    Wright MJ; Woodrow G; Young G; Brownjohn AM; Turney JH
    Nephrol Dial Transplant; 2000 Jun; 15(6):925-6. PubMed ID: 10831667
    [No Abstract]   [Full Text] [Related]  

  • 12. Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis.
    Sirolli V; Di Stante S; Stuard S; Di Liberato L; Amoroso L; Cappelli P; Bonomini M
    Int J Artif Organs; 2000 Jun; 23(6):356-64. PubMed ID: 10919752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The past, present and future of the dialyzer.
    Mineshima M
    Contrib Nephrol; 2015; 185():8-14. PubMed ID: 26023010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beneficial effect of AN69 membranes on anemia in hemodialyzed patients].
    García Cortés MJ; Sánchez Perales MC; Liébana A; Gil JM; Borrego FJ; Borrego J; Pérez del Barrio P; Serrano P; Pérez Bañasco V
    Nefrologia; 2001; 21(4):370-5. PubMed ID: 11816513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different dialyzer membranes on serum angiotensin-converting enzyme during hemodialysis.
    Docci D; Delvecchio C; Turci F; Baldrati L; Gollini C
    Int J Artif Organs; 1988 Jan; 11(1):28-32. PubMed ID: 2834297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a novel vitamin E coated cellulosic membrane hollow fiber dialyzer.
    Woods HF
    ASAIO J; 2001; 47(5):573. PubMed ID: 11575841
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of the primary and repeated use of dialyzers with different membranes on the degree of dialysis-induced leukopenia].
    Strokov AG; Baeva LB; Levitskiĭ ER
    Med Tekh; 1990; (5):16-8. PubMed ID: 2273963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
    Varela MP; Kimmel PL; Phillips TM; Mishkin GJ; Lew SQ; Bosch JP
    Blood Purif; 2001; 19(4):370-9. PubMed ID: 11574733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.